Research with real-world weight.
MedicineEurope PMC
Verdict: MajorBackground Orforglipron is an oral, non-peptide GLP-1 receptor agonist.
MedicineEurope PMC
Background Hypofractionated radiotherapy is an established alternative to conventional fractionation for breast cancer, but long-term evidence after mastectomy with regional nodal irradiation is scarce.
BiologyarXiv
Recent advances in generative protein design have enabled de novo antibody generation with explicit target and epitope conditioning.
BiologybioRxiv
Motivation: Precursor microRNA (pre-miRNA) prediction is used to prioritize genomic hairpins for miRNA annotation.
ClimateOpenAlex
PhysicsarXiv
arXiv
State tracking requires an update at every input, but the depth a Transformer applies to each token is fixed regardless of sequence length.
arXiv
Recent advances in generative protein design have enabled de novo antibody generation with explicit target and epitope conditioning.
Europe PMC
Background Orforglipron is an oral, non-peptide GLP-1 receptor agonist.
OpenAlex
Numerous subseasonal-to-seasonal (S2S) models exist, yet their performance over tropical regions remains poorly understood, leaving forecasters with little guidance on which models best suit operational downscaling.
arXiv
Estimates of the quantum resources needed to run fault-tolerant algorithms are almost always reported as single numbers, even though they rest on uncertain hardware parameters and on cost models that disagree.